Aggravation of diabetic nephropathy in OLETF rats by Thy-1.1 nephritis

Bagchus WM, Hoedemaeker PJ, Rozing J, Bakker WW. Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat. Lab Invest. 1986;55:680–7.

Yamamoto T, Wilson CB. Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int. 1987;32:514–25.

Jefferson JA, Johnson RJ. Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J Nephrol. 1999;12:297–307.

Riley SG, Evans RA, Davies M, Floege J, Phillips AO. Goto-Kakizaki rat is protected from proteinuria after induction of anti-Thy1 nephritis. Am J Kidney Dis. 2002;39:985–1000.

Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 1992;41:1422–8.

Kimmelstiel P, Wilson C. Intercapillary lesions in glomeruli of kidney. Am J Pathol. 1936;12:83–97.

Cavallo T, Pinto JA, Rajaraman S. Immune complex disease complicating diabetic glomerulosclerosis. Am J Nephrol. 1984;4:347–54.

Kanauchi M, Kawano T, Dohi K. Serum IgA levels in patients with diabetic nephropathy and IgA nephropathy superimposed on diabetes mellitus. Diabetes Res Clin Pract. 2000;48:113–8.

Padilla B, Weiss M, Kant KS. Henoch–Schonlein purpura in a patient with diabetic nephropathy: case report and a review of the literature. Am J Kidney Dis. 1992;20:191–4.

Bertani T, Olesnicky L, Abu-Regiaba S, Glasberg S, Pirani CL. Concomitant presence of three different glomerular diseases in the same patient. Report of a case and review of the literature. Nephron. 1983;34:260–6.

Chihara J, Takebayashi S, Taguchi T, Yokoyama K, Harada T, Naito S. Glomerulonephritis in diabetic patients and its effect on the prognosis. Nephron. 1986;43:45–9.

Van der Niepen P, Van den Houte K, Verbeelen D. Schönlein–Henoch glomerulonephritis complicating diabetic glomerulosclerosis. Nephrol Dial Transplant. 1995;10:1254–5.

Peces R, Sanchez A, de la Torre M, Blanco J. Schönlein–Henoch glomerulonephritis complicating diabetic glomerulosclerosis. Nephrol Dial Transplant. 1994;9:1642–4.

Grcevska L, Petrusevska G, Dzikova S, Kostadinova S, Polenakovic M. Membranoproliferative glomerulonephritis complicating diabetic nephropathy. Prilozi. 2005;26:53–61.

Bloodworth JM Jr. A re-evaluation of diabetic glomerulosclerosis 50 years after the discovery of insulin. Hum Pathol. 1978;9:439–53.

Morita T, Churg J. Mesangiolysis. Kidney Int. 1983;24:1–9.

Matsumoto T, Kobayashi T, Wachi H, Seyama Y, Kamata K. Vascular NAD(P)H oxidase mediates endothelial dysfunction in basilar arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Atherosclerosis. 2007;192:15–24.

Matsumoto T, Kobayashi T, Kamata K. Mechanisms underlying the impaired EDHF-type relaxation response in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Eur J Pharmacol. 2006;538:132–40.

Kagota S, Yamaguchi Y, Nakamura K, Kunitomo M. Altered endothelium-dependent responsiveness in the aortas and renal arteries of Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of non-insulin-dependent diabetes mellitus. Gen Pharmacol. 2000;34:201–9.